Accessibility Menu
Predictive Technology Group logo

Predictive Technology Group(OTC) PRED

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-100%
1 Year+0%
1 Month+0%
N/A
Predictive Technology Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-05
Predictive Technology Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-21
1 month+0%USD 0.002026-07-06
3 month+0%USD 0.002026-05-06
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-30
3 year-99.5%USD 0.002023-08-04
5 year-100%USD 0.182021-08-06
Since inception-100%USD 200.002008-01-02

Predictive Technology Group Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$19.17M

Net Income (TTM)

-$68.28M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 27, 2024

PRED News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Predictive Technology Group

Predictive Technology Group, Inc. specializes in innovative molecular diagnostic and therapeutic solutions, focusing on human cellular and tissue-based products. The company operates primarily in the biotechnology sector, offering services that address infertility and regenerative medicine.

Products and Services
  • FertilityDX genetic testing for couples facing infertility
  • ARTguide, a genetic test for women with infertility linked to endometriosis
  • Regenerative medicine products like AmnioCyte and CoreCyte
Growth Outlook
  • Recent revenue of $6.89 million indicates strong market demand
  • Partnership with Atrin Pharmaceuticals enhances diagnostic capabilities
  • Focus on expanding product offerings in regenerative medicine
Financial Highlights
  • Trailing twelve months (TTM) revenue of $20.5 million shows growth potential
  • Gross profit margin improved to 15.8% in the latest quarter
  • Operating expenses decreased by 10% compared to the previous quarter
Predictive Technology Group, Inc. has positioned itself as a key player in the biotechnology industry, particularly in the areas of infertility and regenerative medicine. The company's innovative products, such as FertilityDX and ARTguide, cater to a growing market of couples seeking solutions for infertility. Additionally, the regenerative medicine segment, featuring products like AmnioCyte and CoreCyte, reflects the company's commitment to advancing healthcare solutions. The recent financial performance indicates a positive trajectory, with a notable revenue increase to $6.89 million in the latest quarter. This growth is supported by a strategic partnership with Atrin Pharmaceuticals, which aims to enhance molecular diagnostic tools for cancer treatment. The focus on expanding product offerings in regenerative medicine further underscores the company's potential for future growth. Financially, the trailing twelve months revenue of $20.5 million highlights the company's ability to generate income, while the improved gross profit margin of 15.8% demonstrates operational efficiency. A reduction in operating expenses by 10% compared to the previous quarter suggests effective cost management strategies are being implemented. Overall, Predictive Technology Group, Inc. presents a compelling opportunity for investors interested in the biotechnology sector, particularly in innovative solutions for infertility and regenerative medicine.
AI Generated • Jul 28, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Salt Lake City, UT 84109, US

PRED Financials

Key Financial Metrics (TTM)

Gross Margin

15.78%

Operating Margin

-190.92%

Net Income Margin

-351.44%

Return on Equity

-155.36%

Return on Capital

-73.92%

Return on Assets

-102.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$6.64M

Operating Income

-$28.98M

EBITDA

-$70.04M

Operating Cash Flow

-$7.33M

Capital Expenditure

-$768.23K

Free Cash Flow

-$8.10M

Cash & ST Invst.

$151.99K

Total Debt

$13.44M

Predictive Technology Group Performance Analysis

Predictive Technology Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-30-45.5%
Q12020-09-3063.1%
Q22020-12-31-20.1%
Q32021-03-3169.5%
Predictive Technology Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-30-200.4%
Q12020-09-3063.1%
Q22020-12-3154.0%
Q32021-03-31-4.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$6.89M

+20.4%

Gross Profit

$3.98M

+167.6%

Gross Margin

57.68%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

62

N/A

Net Income

-$7.42M

+46.0%

EBITDA

-$4.96M

+48.5%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Total Cash

$151.99K

-26.4%

Total Debt

$13.44M

+130.0%

Accounts Receivable

$2.42M

+1818.2%

Inventory

$923.34K

-57.8%

Long Term Debt

$3.33M

-22.8%

Short Term Debt

$11.28M

+267.6%

Return on Assets

-1.02%

N/A

Return on Invested Capital

-74.06%

N/A

Free Cash Flow

-$3.30M

-51.7%

Operating Cash Flow

-$3.37M

-56.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PPCBPropanc Biopharma, Inc.
$1.22+0.00%
POTNPotNetwork Holdings, Inc.
$0.00+0.00%
HCLCHealth-Chem Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.00+0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.77+0.01%
ONDSOndas
$9.23+0.04%
SPCXSpace Exploration Technologies
$139.99-0.01%

Questions About PRED

What is the current price of Predictive Technology Group?

Predictive Technology Group is trading at N/A per share.

What is the 52-week range for Predictive Technology Group?

Over the past 52 weeks, Predictive Technology Group has traded between N/A and N/A.

How much debt does Predictive Technology Group have?

Predictive Technology Group total debt is unavailable.

How much cash does Predictive Technology Group have on hand?

Predictive Technology Group does not have cash on hand data available.

What is Predictive Technology Group’s dividend yield?

Predictive Technology Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services